Notes
Slide Show
Outline
1
Case Discussion
  • Israel Society of Hypertension
  • Dead Sea
  • March, 2009
2
Recap relevant data
  • Male, 37y, BMI 19.5, heavy smoker
  •    Admitted with:
  • Hypertensive urgency (BP186/125,190/126)
  • Hyponatremia (Na 121 mEq/L)
  • Hypokalemia   (K 2.0 mEq/L)
  • Pure nephrotic syndrome (bland sediment)
  • Normal renal function
3
On admission
  • Per anamnesis – Right popliteal vein thrombosis (2001)


  • Hypercoagulability workup
  •     Factor V Leiden heterozygote
  •     Primary APLA syndrome (APS)
  •       - lupus anticoagulant positive
  •       - APLA IgM, IgG markedly elevated
4
Patient’s hypertension
  • Relatively recent onset – 6/12 history
  • Not investigated
  • Inadequately treated
  •     - atenolol only ?
  •     - patient compliance
5
Patient’s hypertension
  • Per history – Left loin pain
  • Renal sonography – LK 8.5cm, RK 12.5cm
  •    (compensatory growth)
  • Doppler US – RI left 0.9, right 0.5
  • Renal scan – Non functioning LK (?1%)
  • Abdo CT – Contracted LK, weak nephrographic effect
  • 1998 – CT showed 2 normal sized kidneys
6
Patient’s hypertension
  • Since 1998, probably as of 6/12 , developed contracted left kidney
  • Thrombosed left main renal artery
  • High renin hypertension


  • Renovascular HTN (2 kidney, one clip Goldblatt)
7
 
8
Patient’s course
9
Conclusions
  • ACEI/spironolactone – BP well controlled
  • Electrolyte abnormalities corrected
  • Protein excretion reduced - ? parallel to BP reduction
  • Patient incompliant
10
Electrolyte abnormalities and renovascular HTN

  • Hypokalemia – secondary hyperaldosteronism


  • Hyponatremia – Why?



11
Hyponatremia and RVHTN

  • Not a reported textbook feature of RVHTN
  • AII promotes Na reabsorption/ACEI natriuretic


  • Our patient – lack of UNa, UOsm
12
Hyponatremia and RVHTN
  • However,


  • AII known dipsogenic (as is hypokalemia)
  • Polydipsia/polyuria
  • Increased ADH secretion
  • Increased atrial β-type natriuretic peptides
13
In summary
  • Hyponatremia
  • Hypokalemia
  • Polydipsia/polyuria
  • RVHTN


  • Hyponatremic hypertensive syndrome


  • Sekkarie et al, AJKD 23;866-868,1994
  • Remuzzi et al ,AJKD 14;170-177, 1989
  • Acta Pediatr 1995;504-7, 2006
14
Nephrotic syndrome and RVHTN
  • Proteinuria in RVHTN may be due to prolonged HTN
  • Usually mild, non-nephrotic range
  • Heavy proteinuria/NS
  • Originates from non-ischemic kidney
  • AII dependent
  • Ameliorates/disappears on ACEI therapy (independent of BP lowering effect)
15
AII and proteinuria/NS
  • Hemodynamic effect - ↑glomerular capillary pressure


  • Increased glomerular permeability – increased size selective pore
  •     Effect abrogated by ACEI



  • [Recent studies – normal glomerulus filters substantial amts of albumin, size/charge selectivity plays little or no role]
16
AII and proteinuria/NS
  • Era of the podocyte
  • Central role in glomerular disease
  •    Functions:
  • Support glom.tuft/architecture
  • Synthesis/maintenance of slit membrane
  • Synthesis/maintenance of GBM
  • Paracrine regulatory functions
17
AII and the podocyte
  • Main players – VEGF,PDGF, TGFβ,AII
  • Interaction podocyte (VEGF), mesangial cell (PDGF) and endothelial cell
  • Podocyte damage – degenerative, inflammatory, dysregulative mechanisms
  • Degenerative – high glom pressure model
  • AII – stimulates VEGF, induces TGF, ↓nephrin expression, induces podocyte apoptosis
18
AII and the podocyte

  • End result – Focal segmental glomerulosclerosis (FSGS)


  • Renal artery stenosis and unilateral FSGS


  •     Alkhunaizi, AJKD 29; 936-941,1997
19
“Lest we forget”

  • Our patient – primary APS


  • Significance re renal manifestations ?
20
Renal disease in APS
  • Occlusion of main renal artery/vein
  • Thrombotic microangiopathy
  • Associated with
  •       - membranous nephropathy
  •       - minimal change disease
  •       - pauci-immune GN
  • Can mimic our patient’s presentation
21
Management options
  • 1. Continue conservative treatment (based       on RAS blockade)
  • 2. Attempt revascularization
  • 3. Selective renal vein renin
  • 4. Renal biopsy non-stenosed kidney
  • 5. Nephrectomy
22
Management options
  • 1. Continue conservative treatment (based       on RAS blockade)
  • 2. Attempt revascularization
  • 3. Selective renal vein renin
  • 4. Renal biopsy non-stenosed kidney
  • 5. Nephrectomy
23
Patient’s course
  • Laparoscopic left nephrectomy
  • Immediate post-op
  •     - normalized BP without medications
  •     - Na/K 139/3.9
  •     - ACR 0.45 → 0.2 g/g
  • 5 year FU (phone) – “everything’s alright”


  • All’s well that ends well